CRBN protein levels were observed to be decreased in our drug-resistant cells, whereas MYC and IKZF3 protein levels were upregulated, similar to IMiD-resistant MM patient cells [11,50,68]. This evidence concerns the gene MYC and Miyoshi myopathy.